About
Immunotherapy to Fight Infections and Inflammation
Areas of Focus
Categories
Small Molecule PharmaceuticalSouthwestern U.S.
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
1
As Collaborator
9
Total Enrollment
2,021
By Phase
PHASE1: 1NA: 8PHASE4: 1
By Status
COMPLETED: 7UNKNOWN: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06847698Lead Sponsor
Single Ascending Dose and Multiple Ascending Dose Study of AVR-48
PHASE1Not yet recruiting
48 participants
Started: Jun 30, 2025 · Completed: Nov 30, 2025
NCT00482651Collaborator
Imaging of Vulnerable Plaques in Coronary Artery Disease by Multidetector Computed Tomography
NACompleted
60 participants
Started: Nov 30, 2007 · Completed: Jan 31, 2012
NCT00519909Collaborator
The Effect of Calcium on Fecal Fat and Energy Excretion
NAUnknown
15 participants
Started: Aug 31, 2007 · Completed: Feb 29, 2008
NCT00389129Collaborator
Danish Aspirin Resistance Trial - Pilot Study
NACompleted
60 participants
Started: Nov 30, 2006 · Completed: Mar 31, 2007
NCT00271752Collaborator
The Procalcitonin and Survival Study
NACompleted
1,200 participants
Started: Jan 31, 2006 · Completed: Sep 30, 2009
Locations (1)
Headquarters
Fort Worth, TX, United States
Map
Loading map...